Jove
Visualize
Contact Us

Related Experiment Videos

Selective laser trabeculoplasty.

Jing-Ming Shi1, Song-Bai Jia

  • 1Department of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.

International Journal of Ophthalmology
|January 1, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The vagus nerve activated by inflammation co-transmits acute visceral pain via the NTS-PVN pathway.

Brain, behavior, and immunity·2026
Same author

A novel <i>CRB1</i> variant presenting as Leber congenital amaurosis-8 with angle-closure glaucoma in a Chinese family.

International journal of ophthalmology·2026
Same author

Fisetin targets multiple signaling pathways to suppress microglia-mediated neuroinflammation and cognitive decline in Alzheimer's disease.

Neuropharmacology·2026
Same author

Earlier onset of chemotherapy-induced neuropathic pain in females by ICAM-1-mediated accumulation of perivascular macrophages.

Science advances·2025
Same author

Gallic acid and loganic acid attenuate amyloid-β oligomer-induced microglia damage via NF-КB signaling pathway.

Neuropharmacology·2024
Same author

Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane.

Biophysical journal·2023
Same journal

Artificial intelligence for diagnosis of keratoconus using Scheimpflug based corneal tomography.

International journal of ophthalmology·2026
Same journal

Falling short of the target: effective cataract surgical coverage and the road to 2030.

International journal of ophthalmology·2026
Same journal

Multimodal imaging features of optic disc melanocytoma in a Chinese population.

International journal of ophthalmology·2026
Same journal

Comparison of posterior scleral reinforcement surgery and repeated low-level red-light therapy in controlling high and super high myopia in Chinese children.

International journal of ophthalmology·2026
Same journal

CORRIGENDUM.

International journal of ophthalmology·2026
Same journal

Curcumin protects the diabetic mouse retina by modulating the Hippo-YAP signaling pathway.

International journal of ophthalmology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Selective laser trabeculoplasty (SLT) effectively lowers intraocular pressure (IOP) for open-angle glaucoma (OAG) and ocular hypertension (OHT). This repeatable procedure offers a safe alternative to medications and is suitable for various glaucoma types.

Area of Science:

  • Ophthalmology
  • Glaucoma Management
  • Laser Therapy

Background:

  • Open-angle glaucoma (OAG) and ocular hypertension (OHT) require effective intraocular pressure (IOP) reduction.
  • Traditional treatments include medications and argon laser trabeculoplasty (ALT), with limitations.
  • Selective laser trabeculoplasty (SLT) emerged as a novel therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy and safety of selective laser trabeculoplasty (SLT) for IOP reduction.
  • To compare SLT with existing treatments like medical therapy and ALT.
  • To explore SLT's applicability across diverse glaucoma subtypes and as a primary treatment.

Main Methods:

  • Review of studies assessing SLT for IOP reduction in OAG and OHT.
  • Analysis of SLT's effectiveness compared to medical therapy and ALT.
Keywords:
intraocular pressureopen angle glaucomaselective laser trabeculoplasty

Related Experiment Videos

  • Assessment of SLT's repeatability and safety profile, including adverse events.

    • Main Results:

    • SLT demonstrates comparable IOP-lowering efficacy to medical therapy and ALT.
    • SLT is effective in various glaucoma types, including those previously treated with ALT.
    • The procedure is repeatable due to minimal damage to the trabecular meshwork (TM).

    Conclusions:

    • Selective laser trabeculoplasty (SLT) is a safe and effective treatment for reducing IOP in OAG and OHT.
    • SLT offers a repeatable, non-damaging alternative for IOP management.
    • It can be considered a primary treatment option, especially for patients with medication compliance issues.